PE-Backed Transnetyx Acquires Laragen
On August 23 Transnetyx, Inc., based in Cordova, Tennessee, announced its acquisition of Laragen, Inc. The financial terms were not disclosed. Laragen is a sequencing and genetic services company in Culver City, California. The company was founded in 1995. Transnetyx, a portfolio company of Thompson Street Capital Partners, is a fully-automated genotyping resource for thousands of researchers in universities, hospitals and bioscience companies around the world. It has genotyped more than 20 million samples in 24 or 72 hours with 99.97% accuracy. The addition of Laragen’s sanger sequencing and next-generation sequencing services to the Transnetyx solution suite will... Read More »
PE-Backed STARLIMS Acquires Labstep
STARLIMS, backed by Francisco Partners, announced on August 22 its acquisition of Labstep for an undisclosed price. According to data captured in the LevinPro HC database, this acquisition represents the 92nd Laboratories, MRI and Dialysis transaction of 2023 Labstep is a modern R&D cloud platform helping customers unlock the power of real-time data. Found in more than 900 universities and more than 65 companies worldwide, Labstep’s Electronic Laboratory Notebook (ELN) platform streamlines laboratory work, delivers real-time data capture and collaboration and enhances data integrity. STARLIMS provides enterprise informatics solutions and is committed to providing quality... Read More »
Fortis Life Sciences Acquires International Point of Care
Fortis Life Sciences, backed by Boston-based private equity firm Summit Partners, has acquired Toronto-based International Point of Care (IPOC). IPOC specializes in developing and manufacturing diagnostic components. IPOC serves many of the leading global diagnostic companies enabling the commercialization of new immunodiagnostic and molecular diagnostic technologies. Fortis Life Sciences partners with diagnostics and life sciences companies to custom-design, validate and manufacture proprietary solutions to solve their most difficult development problems. Fortis serves a global customer base and has offices worldwide including four R&D sites and three GMP and ISO 13485 compliant... Read More »
ResMed Acquires Somnoware to Expand Sleep Management Offerings
ResMed announced its acquisition of Somnoware, a Sunnyvale, California-based provider of sleep and respiratory care diagnostics software. Somnoware is a cloud-based platform for enhanced respiratory care management. Somnoware designed its software to streamline the processes of physicians and sleep and pulmonary function testing labs as they diagnose and evaluate sleep and respiratory care test results. Through the platform, positive airway pressure (PAP) therapy can run more efficiently. The software can electronically provide PAP information directly into a patient’s electronic health record. ResMed develops, manufactures and markets medical equipment for the diagnosis, treatment and... Read More »
